Inventor · disambiguated record
Pamela J. Bjorkman
Also filed as: BJORKMAN PAMELA · BJORKMAN PAMELA J
32 granted patents·14 pending applications·322 citations·filing 1993–2025
96Inventor score
Files withCALIFORNIA INST OF TECHN19UNIV ROCKEFELLER18BIO RAD LABORATORIES3The Rockefeller Universtiy2BROAD INST INC1
Top patents by PatentIndex Score
46 records- 0196US9493549B2Antibodies directed toward the HIV-1 GP120 CD4 binding site with increased potency and breadthCALIFORNIA INST OF TECHN·Filed 2012·Granted Nov 15, 2016·55 cites·8 claims
- 0295US12173052B2HIV-1 gp120 CD4 binding site antibodies targeting HIV escape mutantsUNIV ROCKEFELLER·Filed 2021·Granted Dec 24, 2024·2 cites·6 claims
- 0395US12071470B2Human immunodeficiency virus neutralizing antibodies and methods of use thereofUNIV ROCKEFELLER·Filed 2023·Granted Aug 27, 2024·2 cites·22 claims
- 0494US9879068B2Antibodies targeting HIV escape mutantsCALIFORNIA INST OF TECHN·Filed 2013·Granted Jan 30, 2018·12 cites·15 claims
- 0593US9783594B2Human immunodeficiency virus neutralizing antibodies and methods of use thereofSCHEID JOHANNES·Filed 2012·Granted Oct 10, 2017·48 cites·13 claims
- 0690US11149081B2HIV-1 GP120 CD4 binding site antibodies targeting HIV escape mutantsCALIFORNIA INST OF TECHN·Filed 2017·Granted Oct 19, 2021·4 cites·7 claims
- 0790US10047146B2Broadly-neutralizing anti-HIV antibodiesUNIV ROCKEFELLER·Filed 2013·Granted Aug 14, 2018·8 cites·12 claims
- 0889US12428472B2Human immunodeficiency virus neutralizing antibodies and methods of use thereofUNIV ROCKEFELLER·Filed 2024·Granted Sep 30, 2025·0 cites·23 claims
- 0987US5623053ASoluble mammal-derived Fc receptor which binds at a pH ranging from about 5.5 to 6.5 and releases at a pH ranging from about 7.5 to 8.5CALIFORNIA INST OF TECHN·Filed 1993·Granted Apr 22, 1997·132 cites·7 claims
- 1087US2024417449A1Highly active agonistic cd4 binding site anti-hiv antibodies (haads) comprising modified cdrh2 regions that improve contact with gp120CALIFORNIA INST OF TECHN·Filed 2024·Application pending·0 cites
- 1186US9890207B2Highly active agonistic CD4 binding site anti-HIV antibodies (HAADS) comprising modified CDRH2 regions that improve contact with GP120DISKIN RON·Filed 2012·Granted Feb 13, 2018·12 cites·10 claims
- 1286US2025066457A1Antibodies targeting hiv escape mutantsUNIV ROCKEFELLER·Filed 2024·Application pending·0 cites
- 1385US2025115661A1Broadly neutralizing anti-hiv antibodies and epitope thereforUNIV ROCKEFELLER·Filed 2024·Application pending·0 cites
- 1484US12338277B2Broadly neutralizing antibodies that target HIV ENV V3 N-glycansUNIV ROCKEFELLER·Filed 2023·Granted Jun 24, 2025·0 cites·12 claims
- 1583US12054538B2Highly active agonistic CD4 binding site anti-HIV antibodies (HAADS) comprising modified CDRH2 regions that improve contact with GP120CALIFORNIA INST OF TECHN·Filed 2022·Granted Aug 6, 2024·0 cites·3 claims
- 1682US2025320280A1Broadly neutralizing antibodies that target hiv env v3 n-glycansUNIV ROCKEFELLER·Filed 2025·Application pending·0 cites
- 1777US11649276B2Broadly-neutralizing anti-HIV antibodiesUNIV ROCKEFELLER·Filed 2021·Granted May 16, 2023·0 cites·7 claims
- 1877US10590187B2Highly active agonistic CD4 binding site anti-HIV antibodies (HAADS) comprising modified CDRH2 regions that improve contact with gp120CALIFORNIA INST OF TECHN·Filed 2017·Granted Mar 17, 2020·1 cites·5 claims
- 1976US11634478B2Human immunodeficiency virus neutralizing antibodies and methods of use thereofUNIV ROCKEFELLER·Filed 2021·Granted Apr 25, 2023·0 cites·17 claims
- 2075US6924265B2Peptides and peptide analogues designed from HFE protein and their uses in the treatment of iron overload diseasesCALIFORNIA INST OF TECHN·Filed 2001·Granted Aug 2, 2005·3 cites·4 claims
- 2174US11897940B2Broadly neutralizing anti-HIV-1 antibodies and methods of use thereofUNIV ROCKEFELLER·Filed 2022·Granted Feb 13, 2024·0 cites·9 claims
- 2272US11155605B2Nucleic acids encoding broadly neutralizing glycan-dependent 8ANC195 antibody variants that bind to an epitope spanning both HIV-1 ENV subunitsUNIV ROCKEFELLER·Filed 2019·Granted Oct 26, 2021·0 cites·11 claims
- 2372US7119170B2Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseasesCALIFORNIA INST OF TECHN·Filed 2002·Granted Oct 10, 2006·4 cites·5 claims
- 2472US2022002391A1Broadly Neutralizing Anti-HIV Antibodies and Epitope ThereforUNIV ROCKEFELLER·Filed 2021·Application pending·0 cites
- 2571US11472868B2Highly active agonistic CD4 binding site anti-HIV antibodies (HAADS) comprising modified CDRH2 regions that improve contact with GP120CALIFORNIA INST OF TECHN·Filed 2020·Granted Oct 18, 2022·0 cites·5 claims
- 2669US11142564B2Broadly-neutralizing anti-HIV antibodiesThe Rockefeller Universtiy·Filed 2019·Granted Oct 12, 2021·0 cites·12 claims
- 2768US6391852B1Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseasesBIO RAD LABORATORIES·Filed 1998·Granted May 21, 2002·18 cites·3 claims
- 2867US10392433B2Broadly neutralizing antibody directed against HIV-1 GP140The Rockefeller Universtiy·Filed 2018·Granted Aug 27, 2019·0 cites·12 claims
- 2966US10889633B2Human immunodeficiency virus neutralizing antibodies and methods of use thereofUNIV ROCKEFELLER·Filed 2017·Granted Jan 12, 2021·0 cites·12 claims
- 3064US12459990B2Anti-HIV vaccine antibodies with reduced polyreactivityCALIFORNIA INST OF TECHN·Filed 2020·Granted Nov 4, 2025·0 cites·13 claims
- 3163US12440553B2Multivalent carriers and related vaccine compositionsCALIFORNIA INST OF TECHN·Filed 2021·Granted Oct 14, 2025·0 cites·29 claims
- 3263US7329650B2Peptides and peptide analogues designed from HFE protein and their uses in the treatment of iron overload diseasesBIO RAD LABORATORIES·Filed 2005·Granted Feb 12, 2008·0 cites·11 claims
- 3363US6284732B1Peptides and peptide analogues designed from HFE protein and their uses in the treatment of iron overload diseasesCALIFORNIA INST OF TECHN·Filed 1998·Granted Sep 4, 2001·21 cites·7 claims
- 3463US2022402977A1Self-assembling viral spike-eabr nanoparticlesCALIFORNIA INST OF TECHN·Filed 2022·Application pending·0 cites
- 3561US12239698B2HIV vaccine immunogensUNIV ROCKEFELLER·Filed 2019·Granted Mar 4, 2025·0 cites·14 claims
- 3661US11325966B2Broadly neutralizing anti-HIV-1 antibodies and methods of use thereofUNIV ROCKEFELLER·Filed 2017·Granted May 10, 2022·0 cites·16 claims
- 3761US2024083982A1Therapeutic neutralizing antibodies for sars-cov-2CALIFORNIA INST OF TECHN·Filed 2023·Application pending·0 cites
- 3860US7374892B2Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseasesBIO RAD LABORATORIES·Filed 2006·Granted May 20, 2008·0 cites·1 claims
- 3959US10421803B2Broadly neutralizing glycan-dependent 8ANC195 antibody variants that bind to an epitope spanning both HIV-1 Env subunitsUNIV ROCKEFELLER·Filed 2015·Granted Sep 24, 2019·0 cites·9 claims
- 4059US2024033341A1Hiv vaccine immunogensCALIFORNIA INST OF TECHN·Filed 2023·Application pending·0 cites
- 4159US2025011396A1Multivalent carriers and related vaccine compositionsCALIFORNIA INST OF TECHN·Filed 2024·Application pending·0 cites
- 4258US2024294613A1Cross-neutralizing sars-cov2 antibodiesBROAD INST INC·Filed 2021·Application pending·0 cites
- 4355US2023250157A1Antibodies for coronavirus and uses thereofCALIFORNIA INST OF TECHN·Filed 2022·Application pending·0 cites
- 4450US2025144197A1Hiv vaccine immunogensUNIV ROCKEFELLER·Filed 2025·Application pending·0 cites
- 4537US2016102137A1Crosslinked anti-hiv-1 compositions for potent and broad neutralizationCALIFORNIA INST OF TECHN·Filed 2015·Application pending·0 cites
- 4631US2012094935A1Methods for creating or identifying compounds that bind tumor necrosis factor alphaWEST ANTHONY P·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Pamela J. Bjorkman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →